Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance | AVESİS

Istanbul University Research Information System

Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

Copy For Citation

Erbilgin Y., Eskazan A. E., NG O. H., Salihoglu A., Elverdi T., Firtina S., ...More

55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 7 - 10 December 2013, vol.122

Publication Type: Conference Paper / Summary Text
Volume: 122
Doi Number: 10.1182/blood.v122.21.384.384
City: Louisiana
Country: United States Of America
Istanbul University Affiliated: Yes